ABT-202

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.^[1][2][3]

ABT-202

Identifiers
IUPAC name (R)-1-(Pyridin-3-yl)pyrrolidin-3-amine
CAS Number	309959-34-0 N
PubChem CID	39220800
ChemSpider	16397614 Y
UNII	RJ89CX560B
Chemical and physical data
Formula	C9H13N3
Molar mass	163.224 g·mol−1
3D model (JSmol)	Interactive image
SMILES N[C@@H]1CCN(C2=CC=CN=C2)C1
InChI InChI=1S/C9H13N3/c10-8-3-5-12(7-8)9-2-1-4-11-6-9/h1-2,4,6,8H,3,5,7,10H2/t8-/m1/s1 N Key:LVGMMVAWLISWJD-MRVPVSSYSA-N N
NY (what is this?)  (verify)